Prosiectau (7)

Nanoscale structural characterisations of ocular tissues derived from human iPS cells  (01.01.2023  -  31.12.2025)

Near-infrared light therapy as a therapeutic regimen for inherited optic neuropathy  (31.03.2019  -  31.07.2021)

Nicotinamide in Glaucoma (NAMinG): a randomised, placebo-controlled, multicentre, Phase III trial  (01.12.2023  -  30.11.2028)

Novel Area-Modulation Perimetry for identification of visual field loss in glaucoma: market evaluation for the REVAMP+ Study  (06.01.2025  -  30.09.2025)

Novel drug therapy for mitochondrial optic neuropathy and other mitochondrial diseases  (01.05.2016  -  31.12.2018)

Novel modulators of the visual cycle for treatment of retinal degenerations  (01.01.2016  -  31.10.2018)

Novel perimetry for identifying changes in visual field sensitivity in glaucoma  (01.12.2021  -  31.10.2025)